Methods for treating heart arrhythmia

Patent metadata

Field	Value
Publication number	US-8948865-B2
Application number	US-201314081634-A
Country	US
Kind code	B2
Filing date	Nov 15, 2013
Priority date	Apr 8, 2002
Publication date	Feb 3, 2015
Grant date	Feb 3, 2015

Abstract

Methods and apparatus are provided for treatment of heart arrhythmia via renal neuromodulation. Such neuromodulation may effectuate irreversible electroporation or electrofusion, ablation, necrosis and/or inducement of apoptosis, alteration of gene expression, action potential attenuation or blockade, changes in cytokine up-regulation and other conditions in target neural fibers. In some embodiments, such neuromodulation is achieved through application of an electric field. In some embodiments, such neuromodulation is achieved through application of neuromodulatory agents, of thermal energy and/or of high intensity focused ultrasound. In some embodiments, such neuromodulation is performed in a bilateral fashion.

First claim

We claim:

1. A method for treating heart arrhythmia, in a patient in need thereof the method comprising:
introducing a modulation instrument proximate a neural fiber that contributes to renal function of a kidney of the patient; and
delivering energy and/or a neuromodulatory agent to the neural fiber via the modulation instrument in order to modulate a function of the neural fiber, thereby systemically reducing sympathetic tone in the patient.

2. The method of claim 1 , wherein delivering energy further comprises delivering an electric field.

3. The method of claim 2 , wherein delivering the electric field further comprises delivering a pulsed electric field.

4. The method of claim 2 , wherein delivering the electric field further comprises delivering a continuous electric field.

5. The method of claim 1 , wherein delivering a neuromodulatory agent further comprises delivering a drug to the neural fiber.

6. The method of claim 1 , wherein modulating the function of the neural fiber further comprises at least partially denervating the kidney.

7. The method of claim 1 , wherein modulating the function of the neural fiber further comprises inducing an effect in the neural fiber chosen from the group consisting of irreversible electroporation, electrofusion, ablation, necrosis, apoptosis, gene expression alteration, cytokine up-regulation alteration, and combinations thereof.

8. The method of claim 1 , wherein delivering energy further comprises delivering thermal energy.

9. The method of claim 1 , wherein delivering energy further comprises delivering high intensity focused ultrasound.

10. The method of claim 1 , wherein systemically reducing sympathetic tone in the patient further comprises decreasing a load on a heart of the patient.

11. A method for treating heart arrhythmia, in a patient in need thereof the method comprising:
introducing a modulation instrument proximate a neural fiber that contributes to renal function of a kidney of the patient; and
delivering energy and/or a neuromodulatory agent to the neural fiber via the modulation instrument in order to modulate a function of the neural fiber, thereby decreasing a load on a heart of the patient.

12. The method of claim 11 , wherein delivering energy further comprises delivering an electric field.

13. The method of claim 12 , wherein delivering the electric field further comprises delivering a pulsed electric field.

14. The method of claim 12 , wherein delivering the electric field further comprises delivering a continuous electric field.

15. The method of claim 11 , wherein delivering the neuromodulatory agent further comprises delivering a drug to the neural fiber.

16. The method of claim 11 , wherein modulating the function of the neural fiber further comprises at least partially denervating the kidney.

17. The method of claim 11 , wherein modulating the function of the neural fiber further comprises inducing an effect in the neural fiber chosen from the group consisting of irreversible electroporation, electrofusion, ablation, necrosis, apoptosis, gene expression alteration, cytokine up-regulation alteration, and combinations thereof.

18. The method of claim 11 , wherein delivering the energy further comprises delivering thermal energy.

19. The method of claim 11 , wherein delivering the energy further comprises delivering high intensity focused ultrasound.

20. The method of claim 11 , wherein decreasing the load on the heart of the patient further comprises systemically reducing sympathetic tone in the patient.

Assignees

• Medtronic Ardian Luxembourg

Inventors

• Zarins Denise
• Gifford Iii Hanson

Classifications

• A61F7/007

  characterised by electric heating · CPC title

• A61B18/04

  by heating (by applying electromagnetic radiation A61B18/18) · CPC title

• A61M2210/1082

  Kidney · CPC title

• C12Y304/24069

  Bontoxilysin (3.4.24.69), i.e. botulinum neurotoxin · CPC title

• A61N1/32

  alternating or intermittent currents {(applying electric fields by inductive or capacitive coupling A61N1/40; microwave apparatus A61N5/02)} · CPC title